Rationally Designed Small Molecules That Target Both the DNA and RNA Causing Myotonic Dystrophy Type 1

2015 ◽  
Vol 137 (44) ◽  
pp. 14180-14189 ◽  
Author(s):  
Lien Nguyen ◽  
Long M. Luu ◽  
Shaohong Peng ◽  
Julio F. Serrano ◽  
H. Y. Edwin Chan ◽  
...  
Biochemistry ◽  
2020 ◽  
Vol 59 (37) ◽  
pp. 3463-3472
Author(s):  
Lauren D. Hagler ◽  
Long M. Luu ◽  
Marco Tonelli ◽  
JuYeon Lee ◽  
Samuel M. Hayes ◽  
...  

2019 ◽  
Vol 20 (16) ◽  
pp. 4017 ◽  
Author(s):  
Kaalak Reddy ◽  
Jana R. Jenquin ◽  
John D. Cleary ◽  
J. Andrew Berglund

This review, one in a series on myotonic dystrophy (DM), is focused on the development and potential use of small molecules as therapeutics for DM. The complex mechanisms and pathogenesis of DM are covered in the associated reviews. Here, we examine the various small molecule approaches taken to target the DNA, RNA, and proteins that contribute to disease onset and progression in myotonic dystrophy type 1 (DM1) and 2 (DM2).


2012 ◽  
Vol 7 (5) ◽  
pp. 856-862 ◽  
Author(s):  
Jessica L. Childs-Disney ◽  
Jason Hoskins ◽  
Suzanne G. Rzuczek ◽  
Charles A. Thornton ◽  
Matthew D. Disney

2013 ◽  
Vol 4 (1) ◽  
Author(s):  
Jessica L. Childs-Disney ◽  
Ewa Stepniak-Konieczna ◽  
Tuan Tran ◽  
Ilyas Yildirim ◽  
HaJeung Park ◽  
...  

2018 ◽  
Vol 97 (1) ◽  
pp. 78-81
Author(s):  
E.A. Mamaeva ◽  
◽  
L.A. Fedorova ◽  
S.E. Voronovich ◽  
V.D. Nazarov ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document